AdvaMed Fights to Keep User Fees Out of Sequester Cuts for FDA
With more than 5% of the FDA's budget on the chopping block this week, medical device industry lobby AdvaMed vows to fight "shoulder to shoulder" with the watchdog agency to avert cuts that could impact medical innovation.
The medical device industry doesn't want user fees paid by industry to be included in a series of cuts slated for the FDA's budget this week.
The federal watchdog agency will have $210 million, or about 5.1% of its $4.1 billion budget, cut from its 2013 budget March 1 as a result of sequestration, the bargain between the White House and Congress.
Included in those cuts are the user fees medical device and pharmaceutical companies pay in order to insure timely reviews of new drugs and devices.